Hi, what are you looking for?
Jewish Business News
Search results for "Teva Pharmaceutical Industries "
IPOs
– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday, VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus...
Business
– The European Patent Office ruled in favor of Teva in a patent opposition proceeding filed by Synthon and Mylan. – Teva Pharmaceutical...
Business
– Novartis had signed an MOU to acquire the stem cell treatment company for up to $600 million. – Elbit Medical Technologies Ltd. (TASE:EMTC)...
Leadership & A-List
– – Former Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) CEO Shlomo Yanai has been appointed chairman of US drug development company Cambrex Corporation (NYSE: CBM). He...
StartUps
– Synthon says its Phase III clinical trial of glatiramer acetate found an equivalent efficacy and safety profile to Copaxone. – – Dutch drug...
Business
– Clal Biotechnology Industries Ltd. (TASE: CBI) has signed a non-binding letter of intent to sell diabetes treatment developer Andromeda Biotech Ltd. to a US pharmaceutical company for...
Money
– – Eyal Ofer is the richest Israeli, with a fortune of $6.7 billion, followed by his brother, Idan Ofer, with a fortune of...
IPOs
– Galmed Pharmaceuticals Ltd., a clinical-stage biotech developing therapies for liver diseases and gallstones, filed on Thursday with the SEC to raise up to $35...
IPOs
– The burn and wound treatment company MediWound plans to raise $100m on Nasdaq at a $400 million valuation. – In the coming weeks, several Israeli...
StartUps
– The Adverse Event Profile for Rolapitant was Consistent with Earlier Clinical Trials. Preparations Continue in Support of Submission of a New Drug Application...